Zitter JN, Mazonson PD, Miller DP, Hulley SB, Balmes JR. Aircraft cabin air recirculation and symptoms of the common cold. JAMA. July 24/31 2002; 288(4): 483-486.
Schonfeld WH, Villa KF, Fastenau JM, Mazonson PD, Falanga V. An economic assessment of Apligraf (graftskin) for the treatment of hard-to-heal venous leg ulcers. Wound Repair and Regeneration. Jul/Aug 2000; 8(4): 251-70.
Reisner C, Ferguson GT, Mandel MM Gondek K, Gross K, Silva S, Santas CC, Witek TJ. Claims-based comorbidity index correlates with total charges in chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 1999; 159, A808.
Mazonson P, Villa K, Wyse R. Drug Capitation in US Managed Care. Scrip Reports. Surrey, UK: PJB Publications; 1998.
Bates M, Lieu D, Zagari M, Spier A, Williamson T. A pharmacoeconomic evaluation of the use of dexrazoxane in preventing anthracylcine-induced cardiotoxicity in patients with Stage IIIB or IV metastatic breast cancer. Clinical Therapeutics. 1997;19(1):167-184.
Bates MM, Tasch R, Zagari MJ, Williamson T. Cost effectiveness of dexrazoxane cardioprotection in patients receiving FAC chemotherapy: a comparison between the US and Canada. International Society for Technology Assessment in Health Care (ISTAHC). 1997. Barcelona, Spain. Poster presentation.
Mathias SD, Bates MM, Pasta DJ, Cisternas MG, Feeny D, Patrick DL. Use of the Health Utilities Index with stroke patients and their caregivers. Stroke. 1997;28:1888-1894.
Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R, Carroll PR and the CaPSURE Research Panel. The CaPSURETM Database: a methodology for clinical practice and research in prostate cancer. Urology. 1996; 48:773-777.
Zagari MJ, Mazonson P, Longton WC. Pharmacoeconomics of chronic non-malignant pain. PharmacoEconomics. 1996; Oct 1996; 10(4):356-377.
Mazonson P, Mathias S, Fifer S, et al. The mental health patient profile: does it change primary care physicians' practice patterns? Journal of the American Board of Family Practice. 1996; 9:336-345.
Lubeck DP, Moynihan C, Tasch RF, Mazonson PD. Cost of treatment for Alzheimer's disease patients: an analysis of California Medicaid expenditures. Medical Care. 1996; Submitted.
Kunz K, Mazonson P. The role of outcomes research in improving the quality of medical care. Surgical Technology International V. San Francisco, Calif: Universal Medical Press; 1996:63-66.
Kunz K, Kuppermann M, Bowe T, Williamson A, Mazonson P. Cost effectiveness of protein A immunoadsorption column versus splenectomy in the treatment of steroid-resistant immune thrombocytopenic purpura. International Journal of Technology Assessment in Health Care. 1996; 12(3):436-449.
Mazonson P, Zagari M, Freston JW. Shortening the time between the availability of new medical information and its adoption in general practice: the example of acid-related disease. Medical Interface. 1996; 9:71-77.
Mathias SD, Bates M, Pasta DJ, Cisternas M, Donohue J. Health state preferences and utility values for stroke patients and their proxy caregivers. Third Annual Symposium of Contributed Papers on Quality-of-Life Evaluation. 1996. Paper presentation. Published in Drug Information Journal 30(3):855.
Mathias SD, Bates M, Pasta DJ, Cisternas M, Donohue J. The quality of life of stroke patients and the degree of caregiver burden. Third Annual Symposium of Contributed Papers on Quality-of-Life Evaluation. 1996. Poster presentation. Published in Drug Information Journal 30(3):855-856.
Tonkin K, Bates M, Lieu D, Arundell E, Williamson T, Zagari M. Dexrazoxane cardioprotection for patients receiving FAC chemotherapy: a pharmacoeconomic evaluation. Canadian Journal of Oncology. 1996;6(2):458-473.
Kunz K, Kuppermann M, Moynihan C, Williamson A, Mazonson P. The cost of treatment of endometriosis in the California Medicaid population. The American Journal of Managed Care. 1995; 1:25-29.
Kuppermann M, Lubeck DP, Mazonson PD, et al. Sleep problems and their correlates in a working population. Journal of General Internal Medicine. 1995; 10:25-32.
Mathias SD, Fifer SK, Mazonson PD, Lubeck DP, Buesching DP, Patrick DL. Necessary but not sufficient: the effect of screening and feedback on outcomes of primary care patients with untreated anxiety. Journal of General Internal Medicine. 1994; 9:606-615.
Lubeck DP, Mazonson PD, Bowe T. Potential effect of tacrine on expenditures for Alzheimer's Disease. Pharmacoeconomics. October 1994:130-138.
Fifer SK, Mathias SD, Patrick DL, Mazonson PD, Lubeck DP, Buesching DP. Untreated anxiety among adult primary care patients in a health maintenance organization. Archives of General Psychiatry. 1994; 51:740-750.
Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in chronic arthritis has sustained health benefits while reducing health care costs. Arthritis and Rheumatism. 1993; 36:439-446.
Mazonson P. Getting physicians involved. Pharmaceutical Outcomes News. April 1993.
Lubeck DP, Bennett CL, Mazonson PD, Fifer SK, Fries JF. Quality-of-life and health service use among HIV-infected patients with chronic diarrhea. Journal of Acquired Immune Deficiency Syndromes. 1993; 6:478-484.
Mazonson PD, Williams ML, Cantley LK, Utiger RD, Foster JR. Myxedema coma during chronic amiodarone therapy. American Journal of Medicine. 1984; 77:751-754.
Mazonson PD, We AHT, Scaltrito SH. Oncology grand rounds: The need for case-orientated continuing education programs in cancer nursing. Cancer Nursing. 1981; April:107-114.
Levine MD, Mazonson PD, Bakow H. Behavioral symptom substitution in children cured of encopresis. American Journal of Diseases of Childhood. 1980, 134:663-667.
|HOME||© 2008 Mosaic Health Care Consultants. All Rights Reserved.|